Yahoo Web Search

Search results

1. • Flu Breakthrough: Vanderbilt Scientists Discover Powerful New Weapon

     SciTechDaily· 3 hours ago

     Vanderbilt University researchers have identified potent monoclonal antibodies against influenza B, showcasing a promising avenue for treatment and preventative ...

2. • Researchers take step toward development of universal COVID-19 antibodies

     Valley City Times Record· 7 days ago

     SARS-CoV-2, the virus that causes COVID-19 disease, continues to evolve and evade current vaccine and therapeutic interventions. A consortium of scientists at Texas Biomedical ...

3. • 

     A Guide to Managing Covid This Summer

     New York Times· 3 days ago

     Here’s what to know about symptoms, testing and treatment. KP.2, one of these variants, now accounts for 28.5 percent of cases, and data from the Centers...

4. • Small Business - The Roanoke-Chowan News-Herald | The Roanoke-Chowan News-Herald

     Roanoke-Chowan News-Herald· 6 days ago

     Food and Drug Administration (FDA) on an expedient, repeatable immunobridging pathway to future potential emergency use authorizations (EUAs) for serial, novel monoclonal ...

5. • 

     Invivyd aligns with FDA on rapid mAb trial pathway By Investing.com

     Investing.com· 6 days ago

     Food and Drug Administration (FDA) on a new clinical trial pathway for the expedited development of ...

6. • 

     The Push to Get More People Into Long COVID Studies

     Medscape· 2 days ago

     Last spring, he enrolled in a clinical trial of a new long COVID therapy at Stanford University, and he's about to start another at the University of...

7. • 

     Invivyd appoints new Chief Commercial Officer ahead of PEMGARDA launch By Investing.com

     Investing.com· 6 days ago

     Invivyd, Inc. (NASDAQ:IVVD), a company focused on developing treatments for viral infectious...

8. • 

     EMA Panel Nods to Seven New Cancer Drugs

     Medscape· 6 days ago

     The drugs include an anti–PD-L1 monoclonal antibody, a biosimilar, and five generics, with indications covering a wide spectrum of cancers.

9. • MS Med Nearly Eliminates Disease Activity on MRI

     Medscape· 1 day ago

     A second-generation anti-CD40L monoclonal antibody suppresses multiple sclerosis (MS) disease activity on MRI to an uncommonly high degree, new trial data ...

10. • 

      Fauci Grilled by Lawmakers on Masks, Vaccine Mandates and Lab Leak Theory

      New York Times· 3 days ago

      Dr. Fauci testified before a House panel investigating Covid’s origins. Dr. Anthony S. Fauci, the...